These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14333024)

  • 1. [EXPERIMENTAL STUDIES AND CLINICAL USE OF ELECTROLYTE-CARRIER COMPOUNDS. 6. ORIENTATIONAL RESEARCH ON MAGNESIUM- AND POTASSIUM-NICOTINYL-ASPARAGINATE (MG + K - NA)].
    NIEPER HA; KOEHLER L
    Arztl Forsch; 1964 Nov; 18():565-7. PubMed ID: 14333024
    [No Abstract]   [Full Text] [Related]  

  • 2. [ANIMAL EXPERIMENTAL STUDIES WITH K-MG-ASPARAGINATE. COMPABILITY, ELIMINATION, AND INFLUENCE ON THE TOXICITY OF CARDIAC GLYCOSIDES].
    GREEFF K; KNIPPERS R
    Arzneimittelforschung; 1964 Oct; 14():1128-34. PubMed ID: 14343476
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE EFFECTS OF ASPARAGINATE SALTS ON EXPERIMENTAL HYPERTENSION, MYOCARDIAL CHANGES AND THE SERUM ELECTROLYTE CONTENT IN RATS].
    SOS J; RIGO J; GATI T
    Arzneimittelforschung; 1964 Oct; 14():1134-6. PubMed ID: 14343477
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental principles and clinical use of electrolyte carrier compounds. 4. The normalizing effect of potassium and magnesium asparaginate on an atypical substrate balance appearing in cancer patients. The importance of the problem for the host organism].
    NIEPER HA
    Arztl Forsch; 1961 Nov; 15():I/510-8. PubMed ID: 14479694
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental basis and clinical use of electrolyte carrier compounds. I. Metabolic activity of Mg- and K-asparaginate, especially in coronary insufficiency].
    NIEPER HA; BLUMBERGER KJ
    Arztl Forsch; 1961 Apr; 15():125-30. PubMed ID: 13728986
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental principles and clinical use of electrolyte carrier compounds. 3. The normalizing effect of magnesium and potassium asparaginate on an atypical substrate balance appearing after prolonged treatment with digitoxin].
    NIEPER HA; BLUMBERGER K
    Arztl Forsch; 1961 Nov; 15():I/507-9. PubMed ID: 14479692
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effectiveness of electrolyte carrier compounds on myocardial metabolism, illustrated by magnesium and potassium asparaginate].
    NIEPER HA; BLUMBERGER K
    Verh Dtsch Ges Kreislaufforsch; 1961; 27():238-42. PubMed ID: 14479693
    [No Abstract]   [Full Text] [Related]  

  • 8. EFFECT OF TOXIC DOSES OF L-THYROXINE ON TISSUE WATER, ELECTROLYTES AND PLASMA PROTEIN IN RATS.
    LIU CT; OVERMAN RR
    Proc Soc Exp Biol Med; 1964 Oct; 117():232-6. PubMed ID: 14223279
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES ON ASPARTIC ACID SALTS. II. BASIC STUDIES].
    MASUDA M; KUZUDANI A; MORI K; OGASAWARA K; IRINO J; TABUCHI K; TOMIKAWA J; INOUE H; NAKANO K; ADACHI H; KANETSUNA H
    Sogo Rinsho; 1964 Apr; 13():696-700. PubMed ID: 14142732
    [No Abstract]   [Full Text] [Related]  

  • 10. EFFECTS OF THE POTASSIUM AND MAGNESIUM SALTS OF ASPARTIC ACID ON AMMONIA INTOXICATION IN THE RAT.
    ROSEN H; BLUMENTHAL A; CONSALVI A
    Acta Pharmacol Toxicol (Copenh); 1963; 20():115-20. PubMed ID: 14060769
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental basis and clinical use of electrolyte carrier compounds. 2. Normalizing effects of Mg- and K-asparaginate on an a typical substrate balance, which appears in prolonged strophanthin treatment].
    NIEPER HA; BLUMBERGER K
    Arztl Forsch; 1961 Jul; 15():305-9. PubMed ID: 13728985
    [No Abstract]   [Full Text] [Related]  

  • 12. [EFFECT OF K, MG-ASPARATE ADMINISTRATION ON FATIGUE].
    OTSUKA S
    Rodo Kagaku; 1964 May; 40():229-31. PubMed ID: 14172898
    [No Abstract]   [Full Text] [Related]  

  • 13. [PHARMACOLOGY OF A NEW ANTITOXIC PRINCIPLE].
    RATSIMAMANGA AR; HALLER PH
    Gaz Med Fr; 1964 Apr; 71():1415-7. PubMed ID: 14143812
    [No Abstract]   [Full Text] [Related]  

  • 14. ESSENTIAL HYPOTENSION: A CLINICAL NONENTITY.
    PODOLSKY S
    Geriatrics; 1964 Jul; 19():476-83. PubMed ID: 14183243
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental bases and clinical uses of electrolyte-carrier compounds. 5. Orientational studies on potassium- and magnesium-2-aminoethanol phosphate (EAP)].
    NIEPER HA
    Arztl Forsch; 1962 Dec; 16():I/641-2. PubMed ID: 13938551
    [No Abstract]   [Full Text] [Related]  

  • 16. [EFFECT OF HIGH INSULIN DOSES ON THE SODIUM, POTASSIUM, AND MAGNESIUM, LEVEL AND TOTAL AND IONIZED CALCIUM CONTENT IN THE BLOOD SERUM].
    FOKIN AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1717-21. PubMed ID: 14339967
    [No Abstract]   [Full Text] [Related]  

  • 17. [TREATMENT OF MYOCARDIAL INFARCTS WITH POTASSIUM-MAGNESIUM-ASPARAGINATE. (CLINICAL OBSERVATION)].
    KENTER H; FALKENHAHN A
    Med Welt; 1964 Aug; 35():1848-52. PubMed ID: 14293128
    [No Abstract]   [Full Text] [Related]  

  • 18. THE MITIGATION OF PHYSICAL FATIGUE WITH "SPARTASE". REP 63-12.
    NAGLE FJ; BALKE B; GANSLEN RV; DAVIS AW
    Rep Civ Aeromed Res Inst US; 1963 Jul; ():1-10. PubMed ID: 14133531
    [No Abstract]   [Full Text] [Related]  

  • 19. ELECTROCARDIOGRAPHIC AND ELECTROLYTE ABNORMALITIES CAUSED BY AMPHOTERICIN B IN DOG AND MAN.
    BUTLER WT; BENNETT JE; HILL GJ
    Proc Soc Exp Biol Med; 1964; 116():857-63. PubMed ID: 14230372
    [No Abstract]   [Full Text] [Related]  

  • 20. POSTOPERATIVE ELECTROLYTE AND WATER METABOLISM ON METHANDROSTENOLONE (DIANABOL) THERAPY.
    HASNER E
    Acta Chir Scand; 1965 Apr; 129():386-90. PubMed ID: 14294399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.